Year: 2015
Type: review
Abstract: Bone remodeling is balanced by bone formation and bone resorption as well as by alterations in the quantities and functions of seed cells, leading to either the maintenance or deterioration of bone status. The existing evidence indicates that microRNAs (miRNAs), known as a family of short non-coding RNAs, are the key post-transcriptional repressors of gene expression, and growing numbers of novel miRNAs have been verified to play vital roles in the regulation of osteogenesis, osteoclastogenesis, and adipogenesis, revealing how they interact with signaling molecules to control these processes. This review summarizes the current knowledge of the roles of miRNAs in regulating bone remodeling as well as novel applications for miRNAs in biomaterials for therapeutic purposes. Short, non-coding microRNAs play a critical role in regulating bone remodeling and provide therapeutic targets for treating bone disease. In a review article, Zhi-He Zhao and colleagues from the State Key Laboratory of Oral Diseases at Sichuan University in Chengdu, China, examine the ways in which microRNAs control gene expression in various types of bone cells, including bone-forming osteoblasts and bone-resorbing osteoclasts. Through this regulatory function, microRNAs can help tip the balance toward bone synthesis or degradation to spur disease processes and affect healthy development. After highlighting some of the specific molecules and pathways impacted by microRNAs at various stages of bone remodeling, the authors discuss how microRNAs could be delivered into the body, either directly or through some kind of biomaterial, to correct skeletal disease, trauma, osteoporosis, cancer and other disorders affecting bone.
DOI: 10.1038/ijos.2015.22
Language: English
Topic: Bone Metabolism and Diseases
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,890
Award: G7801884952
OpenAlex ID: W2168222359
